Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mangana

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2021
Cutaneous SCC with orbital invasion: case seriesM Nägeli, J Mangana, K Chaloupka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 13, 2017
Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanomaV C Amann, D Hoffmann, J Mangana, et al.
ESMO Open|November 16, 2016
A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosisD Jenni, M B Karpova, B Mühleisen, et al.
The British Journal of Dermatology|December 15, 2015
Prognostic relevance of lactate dehydrogenase and serum S100 levels in stage IV melanoma with known BRAF mutation statusA L Frauchiger, J Mangana, M Rechsteiner, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 8, 2016
Developments in targeted therapy in melanomaV C Amann, E Ramelyte, S Thurneysen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 24, 2018
The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanomaN P Graf, P Koelblinger, N Galliker, et al.
The British Journal of Dermatology|May 12, 2016
An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxelS Thurneysen, P F Cheng, H W Nagel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 29, 2015
Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot studyM Kunz, M Urosevic-Maiwald, S M Goldinger, et al.
The British Journal of Dermatology|January 17, 2021
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differencesC Dessinioti, A C Geller, A Stergiopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2020
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy<sup>☆</sup>C N Owen, A N Shoushtari, D Chauhan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the European Academy of Dermatology and Venereology : JEADV|December 2, 2021
Cutaneous SCC with orbital invasion: case seriesM Nägeli, J Mangana, K Chaloupka, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 13, 2017
Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanomaV C Amann, D Hoffmann, J Mangana, et al.
ESMO Open|November 16, 2016
A prospective clinical trial to assess lapatinib effects on cutaneous squamous cell carcinoma and actinic keratosisD Jenni, M B Karpova, B Mühleisen, et al.
The British Journal of Dermatology|December 15, 2015
Prognostic relevance of lactate dehydrogenase and serum S100 levels in stage IV melanoma with known BRAF mutation statusA L Frauchiger, J Mangana, M Rechsteiner, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 8, 2016
Developments in targeted therapy in melanomaV C Amann, E Ramelyte, S Thurneysen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 24, 2018
The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B-rapidly accelerated fibrosarcoma-mutated advanced melanomaN P Graf, P Koelblinger, N Galliker, et al.
The British Journal of Dermatology|May 12, 2016
An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxelS Thurneysen, P F Cheng, H W Nagel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 29, 2015
Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot studyM Kunz, M Urosevic-Maiwald, S M Goldinger, et al.
The British Journal of Dermatology|January 17, 2021
A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differencesC Dessinioti, A C Geller, A Stergiopoulou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2020
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy<sup>☆</sup>C N Owen, A N Shoushtari, D Chauhan, et al.
Pageof 2